nodes	percent_of_prediction	percent_of_DWPC	metapath
Clarithromycin—SLC22A7—Methotrexate—multiple sclerosis	0.0873	0.123	CbGbCtD
Clarithromycin—ABCB1—Methylprednisolone—multiple sclerosis	0.0544	0.0766	CbGbCtD
Clarithromycin—CYP3A4—Fingolimod—multiple sclerosis	0.0506	0.0713	CbGbCtD
Clarithromycin—CYP3A7—Dexamethasone—multiple sclerosis	0.0422	0.0594	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0422	0.0594	CbGbCtD
Clarithromycin—CYP2C19—Prednisone—multiple sclerosis	0.0409	0.0576	CbGbCtD
Clarithromycin—ABCB1—Mitoxantrone—multiple sclerosis	0.0397	0.0559	CbGbCtD
Clarithromycin—ABCB1—Betamethasone—multiple sclerosis	0.0354	0.0498	CbGbCtD
Clarithromycin—ABCB1—Prednisolone—multiple sclerosis	0.0349	0.0492	CbGbCtD
Clarithromycin—ABCB1—Prednisone—multiple sclerosis	0.033	0.0464	CbGbCtD
Clarithromycin—CYP3A4—Methylprednisolone—multiple sclerosis	0.0326	0.0459	CbGbCtD
Clarithromycin—CYP3A5—Dexamethasone—multiple sclerosis	0.0316	0.0445	CbGbCtD
Clarithromycin—CYP2C19—Dexamethasone—multiple sclerosis	0.0255	0.0359	CbGbCtD
Clarithromycin—CYP3A4—Triamcinolone—multiple sclerosis	0.0247	0.0348	CbGbCtD
Clarithromycin—CYP3A4—Mitoxantrone—multiple sclerosis	0.0238	0.0335	CbGbCtD
Clarithromycin—CYP3A4—Betamethasone—multiple sclerosis	0.0212	0.0299	CbGbCtD
Clarithromycin—CYP3A4—Prednisolone—multiple sclerosis	0.0209	0.0295	CbGbCtD
Clarithromycin—ABCB1—Dexamethasone—multiple sclerosis	0.0206	0.029	CbGbCtD
Clarithromycin—CYP3A4—Prednisone—multiple sclerosis	0.0198	0.0278	CbGbCtD
Clarithromycin—ABCB1—Methotrexate—multiple sclerosis	0.0165	0.0233	CbGbCtD
Clarithromycin—CYP3A4—Dexamethasone—multiple sclerosis	0.0123	0.0174	CbGbCtD
Clarithromycin—SLC22A7—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000661	0.0447	CbGpPWpGaD
Clarithromycin—CYP3A5—Irinotecan Pathway—BCHE—multiple sclerosis	0.000319	0.0216	CbGpPWpGaD
Clarithromycin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000317	0.0214	CbGpPWpGaD
Clarithromycin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000317	0.0214	CbGpPWpGaD
Clarithromycin—CYP3A7—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000313	0.0211	CbGpPWpGaD
Clarithromycin—CYP3A7—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000313	0.0211	CbGpPWpGaD
Clarithromycin—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.0003	0.0203	CbGpPWpGaD
Clarithromycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000272	0.0184	CbGpPWpGaD
Clarithromycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000272	0.0184	CbGpPWpGaD
Clarithromycin—CYP3A7—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000257	0.0174	CbGpPWpGaD
Clarithromycin—CYP3A7—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000257	0.0174	CbGpPWpGaD
Clarithromycin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000229	0.0155	CbGpPWpGaD
Clarithromycin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000229	0.0155	CbGpPWpGaD
Clarithromycin—CYP3A5—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000226	0.0153	CbGpPWpGaD
Clarithromycin—CYP3A5—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000226	0.0153	CbGpPWpGaD
Clarithromycin—Stomatitis—Methotrexate—multiple sclerosis	0.000222	0.000807	CcSEcCtD
Clarithromycin—Angiopathy—Prednisone—multiple sclerosis	0.000222	0.000807	CcSEcCtD
Clarithromycin—Conjunctivitis—Methotrexate—multiple sclerosis	0.000221	0.000805	CcSEcCtD
Clarithromycin—Confusional state—Methylprednisolone—multiple sclerosis	0.000221	0.000805	CcSEcCtD
Clarithromycin—Immune system disorder—Prednisone—multiple sclerosis	0.000221	0.000803	CcSEcCtD
Clarithromycin—Malaise—Dexamethasone—multiple sclerosis	0.000221	0.000802	CcSEcCtD
Clarithromycin—Malaise—Betamethasone—multiple sclerosis	0.000221	0.000802	CcSEcCtD
Clarithromycin—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00022	0.0008	CcSEcCtD
Clarithromycin—Vertigo—Dexamethasone—multiple sclerosis	0.00022	0.000799	CcSEcCtD
Clarithromycin—Vertigo—Betamethasone—multiple sclerosis	0.00022	0.000799	CcSEcCtD
Clarithromycin—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000219	0.000798	CcSEcCtD
Clarithromycin—Infection—Triamcinolone—multiple sclerosis	0.000219	0.000795	CcSEcCtD
Clarithromycin—Infection—Methylprednisolone—multiple sclerosis	0.000218	0.000793	CcSEcCtD
Clarithromycin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000217	0.0147	CbGpPWpGaD
Clarithromycin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000217	0.0147	CbGpPWpGaD
Clarithromycin—Haematuria—Methotrexate—multiple sclerosis	0.000217	0.00079	CcSEcCtD
Clarithromycin—Insomnia—Prednisolone—multiple sclerosis	0.000216	0.000787	CcSEcCtD
Clarithromycin—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000215	0.000783	CcSEcCtD
Clarithromycin—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000215	0.000783	CcSEcCtD
Clarithromycin—Loss of consciousness—Betamethasone—multiple sclerosis	0.000215	0.000781	CcSEcCtD
Clarithromycin—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000215	0.000781	CcSEcCtD
Clarithromycin—Epistaxis—Methotrexate—multiple sclerosis	0.000215	0.000781	CcSEcCtD
Clarithromycin—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000215	0.000781	CcSEcCtD
Clarithromycin—Paraesthesia—Prednisolone—multiple sclerosis	0.000215	0.000781	CcSEcCtD
Clarithromycin—Mental disorder—Prednisone—multiple sclerosis	0.000214	0.000779	CcSEcCtD
Clarithromycin—Nausea—Azathioprine—multiple sclerosis	0.000214	0.000779	CcSEcCtD
Clarithromycin—Skin disorder—Methylprednisolone—multiple sclerosis	0.000213	0.000775	CcSEcCtD
Clarithromycin—Malnutrition—Prednisone—multiple sclerosis	0.000213	0.000774	CcSEcCtD
Clarithromycin—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000213	0.000773	CcSEcCtD
Clarithromycin—Agranulocytosis—Methotrexate—multiple sclerosis	0.000213	0.000773	CcSEcCtD
Clarithromycin—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000212	0.000771	CcSEcCtD
Clarithromycin—Convulsion—Dexamethasone—multiple sclerosis	0.000212	0.00077	CcSEcCtD
Clarithromycin—Convulsion—Betamethasone—multiple sclerosis	0.000212	0.00077	CcSEcCtD
Clarithromycin—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.00021	0.0142	CbGpPWpGaD
Clarithromycin—Asthenia—Mitoxantrone—multiple sclerosis	0.000209	0.000761	CcSEcCtD
Clarithromycin—Myalgia—Betamethasone—multiple sclerosis	0.000208	0.000757	CcSEcCtD
Clarithromycin—Myalgia—Dexamethasone—multiple sclerosis	0.000208	0.000757	CcSEcCtD
Clarithromycin—Anxiety—Dexamethasone—multiple sclerosis	0.000207	0.000754	CcSEcCtD
Clarithromycin—Anxiety—Betamethasone—multiple sclerosis	0.000207	0.000754	CcSEcCtD
Clarithromycin—Discomfort—Betamethasone—multiple sclerosis	0.000206	0.000748	CcSEcCtD
Clarithromycin—Discomfort—Dexamethasone—multiple sclerosis	0.000206	0.000748	CcSEcCtD
Clarithromycin—Haemoglobin—Methotrexate—multiple sclerosis	0.000205	0.000747	CcSEcCtD
Clarithromycin—Pain—Prednisolone—multiple sclerosis	0.000205	0.000744	CcSEcCtD
Clarithromycin—Hepatitis—Methotrexate—multiple sclerosis	0.000204	0.000743	CcSEcCtD
Clarithromycin—Haemorrhage—Methotrexate—multiple sclerosis	0.000204	0.000743	CcSEcCtD
Clarithromycin—Pharyngitis—Methotrexate—multiple sclerosis	0.000203	0.000738	CcSEcCtD
Clarithromycin—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000202	0.000734	CcSEcCtD
Clarithromycin—Urethral disorder—Methotrexate—multiple sclerosis	0.0002	0.000729	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.0002	0.000729	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.0002	0.000727	CcSEcCtD
Clarithromycin—Anaphylactic shock—Betamethasone—multiple sclerosis	0.0002	0.000726	CcSEcCtD
Clarithromycin—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.0002	0.000726	CcSEcCtD
Clarithromycin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000199	0.000725	CcSEcCtD
Clarithromycin—Insomnia—Triamcinolone—multiple sclerosis	0.000199	0.000723	CcSEcCtD
Clarithromycin—Insomnia—Methylprednisolone—multiple sclerosis	0.000198	0.000722	CcSEcCtD
Clarithromycin—Infection—Betamethasone—multiple sclerosis	0.000198	0.000721	CcSEcCtD
Clarithromycin—Infection—Dexamethasone—multiple sclerosis	0.000198	0.000721	CcSEcCtD
Clarithromycin—Ill-defined disorder—Prednisone—multiple sclerosis	0.000198	0.000718	CcSEcCtD
Clarithromycin—Paraesthesia—Triamcinolone—multiple sclerosis	0.000198	0.000718	CcSEcCtD
Clarithromycin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000197	0.000717	CcSEcCtD
Clarithromycin—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000197	0.000717	CcSEcCtD
Clarithromycin—Visual impairment—Methotrexate—multiple sclerosis	0.000197	0.000716	CcSEcCtD
Clarithromycin—Anaemia—Prednisone—multiple sclerosis	0.000197	0.000716	CcSEcCtD
Clarithromycin—Dyspnoea—Triamcinolone—multiple sclerosis	0.000196	0.000713	CcSEcCtD
Clarithromycin—Nervous system disorder—Betamethasone—multiple sclerosis	0.000196	0.000712	CcSEcCtD
Clarithromycin—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000196	0.000712	CcSEcCtD
Clarithromycin—Agitation—Prednisone—multiple sclerosis	0.000196	0.000712	CcSEcCtD
Clarithromycin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000195	0.000711	CcSEcCtD
Clarithromycin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000195	0.000711	CcSEcCtD
Clarithromycin—Angioedema—Prednisone—multiple sclerosis	0.000195	0.000708	CcSEcCtD
Clarithromycin—Dyspepsia—Triamcinolone—multiple sclerosis	0.000194	0.000704	CcSEcCtD
Clarithromycin—Erythema multiforme—Methotrexate—multiple sclerosis	0.000193	0.000703	CcSEcCtD
Clarithromycin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000193	0.000702	CcSEcCtD
Clarithromycin—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000193	0.000702	CcSEcCtD
Clarithromycin—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000193	0.000702	CcSEcCtD
Clarithromycin—Malaise—Prednisone—multiple sclerosis	0.000192	0.000698	CcSEcCtD
Clarithromycin—Vertigo—Prednisone—multiple sclerosis	0.000191	0.000696	CcSEcCtD
Clarithromycin—Eye disorder—Methotrexate—multiple sclerosis	0.000191	0.000695	CcSEcCtD
Clarithromycin—Tinnitus—Methotrexate—multiple sclerosis	0.000191	0.000693	CcSEcCtD
Clarithromycin—Anorexia—Dexamethasone—multiple sclerosis	0.00019	0.000692	CcSEcCtD
Clarithromycin—Anorexia—Betamethasone—multiple sclerosis	0.00019	0.000692	CcSEcCtD
Clarithromycin—Urticaria—Prednisolone—multiple sclerosis	0.00019	0.000691	CcSEcCtD
Clarithromycin—Cardiac disorder—Methotrexate—multiple sclerosis	0.00019	0.00069	CcSEcCtD
Clarithromycin—Fatigue—Triamcinolone—multiple sclerosis	0.00019	0.00069	CcSEcCtD
Clarithromycin—Fatigue—Methylprednisolone—multiple sclerosis	0.000189	0.000688	CcSEcCtD
Clarithromycin—Pain—Triamcinolone—multiple sclerosis	0.000188	0.000684	CcSEcCtD
Clarithromycin—Loss of consciousness—Prednisone—multiple sclerosis	0.000187	0.000681	CcSEcCtD
Clarithromycin—CYP3A5—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000186	0.0126	CbGpPWpGaD
Clarithromycin—CYP3A5—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000186	0.0126	CbGpPWpGaD
Clarithromycin—Angiopathy—Methotrexate—multiple sclerosis	0.000185	0.000674	CcSEcCtD
Clarithromycin—Vomiting—Mitoxantrone—multiple sclerosis	0.000185	0.000674	CcSEcCtD
Clarithromycin—Immune system disorder—Methotrexate—multiple sclerosis	0.000185	0.000671	CcSEcCtD
Clarithromycin—Convulsion—Prednisone—multiple sclerosis	0.000185	0.000671	CcSEcCtD
Clarithromycin—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000184	0.00067	CcSEcCtD
Clarithromycin—Rash—Mitoxantrone—multiple sclerosis	0.000184	0.000668	CcSEcCtD
Clarithromycin—Dermatitis—Mitoxantrone—multiple sclerosis	0.000184	0.000668	CcSEcCtD
Clarithromycin—Chills—Methotrexate—multiple sclerosis	0.000183	0.000667	CcSEcCtD
Clarithromycin—Headache—Mitoxantrone—multiple sclerosis	0.000183	0.000664	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000182	0.000661	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000182	0.000661	CcSEcCtD
Clarithromycin—Myalgia—Prednisone—multiple sclerosis	0.000181	0.000659	CcSEcCtD
Clarithromycin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000181	0.000659	CcSEcCtD
Clarithromycin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000181	0.000658	CcSEcCtD
Clarithromycin—Anxiety—Prednisone—multiple sclerosis	0.000181	0.000657	CcSEcCtD
Clarithromycin—Insomnia—Betamethasone—multiple sclerosis	0.000181	0.000656	CcSEcCtD
Clarithromycin—Insomnia—Dexamethasone—multiple sclerosis	0.000181	0.000656	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00018	0.000655	CcSEcCtD
Clarithromycin—SLC22A7—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00018	0.0122	CbGpPWpGaD
Clarithromycin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000179	0.000653	CcSEcCtD
Clarithromycin—Paraesthesia—Dexamethasone—multiple sclerosis	0.000179	0.000652	CcSEcCtD
Clarithromycin—Paraesthesia—Betamethasone—multiple sclerosis	0.000179	0.000652	CcSEcCtD
Clarithromycin—Discomfort—Prednisone—multiple sclerosis	0.000179	0.000651	CcSEcCtD
Clarithromycin—Mental disorder—Methotrexate—multiple sclerosis	0.000179	0.000651	CcSEcCtD
Clarithromycin—Malnutrition—Methotrexate—multiple sclerosis	0.000178	0.000647	CcSEcCtD
Clarithromycin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000177	0.012	CbGpPWpGaD
Clarithromycin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000177	0.012	CbGpPWpGaD
Clarithromycin—Hypersensitivity—Prednisolone—multiple sclerosis	0.000176	0.000641	CcSEcCtD
Clarithromycin—Dyspepsia—Betamethasone—multiple sclerosis	0.000176	0.000639	CcSEcCtD
Clarithromycin—Dyspepsia—Dexamethasone—multiple sclerosis	0.000176	0.000639	CcSEcCtD
Clarithromycin—Urticaria—Triamcinolone—multiple sclerosis	0.000175	0.000635	CcSEcCtD
Clarithromycin—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000175	0.0118	CbGpPWpGaD
Clarithromycin—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000175	0.0118	CbGpPWpGaD
Clarithromycin—Urticaria—Methylprednisolone—multiple sclerosis	0.000174	0.000634	CcSEcCtD
Clarithromycin—Dysgeusia—Methotrexate—multiple sclerosis	0.000174	0.000634	CcSEcCtD
Clarithromycin—Body temperature increased—Triamcinolone—multiple sclerosis	0.000174	0.000632	CcSEcCtD
Clarithromycin—Anaphylactic shock—Prednisone—multiple sclerosis	0.000174	0.000632	CcSEcCtD
Clarithromycin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000173	0.000631	CcSEcCtD
Clarithromycin—Decreased appetite—Dexamethasone—multiple sclerosis	0.000173	0.000631	CcSEcCtD
Clarithromycin—Decreased appetite—Betamethasone—multiple sclerosis	0.000173	0.000631	CcSEcCtD
Clarithromycin—Nausea—Mitoxantrone—multiple sclerosis	0.000173	0.00063	CcSEcCtD
Clarithromycin—Infection—Prednisone—multiple sclerosis	0.000173	0.000628	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000172	0.000626	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000172	0.000626	CcSEcCtD
Clarithromycin—Back pain—Methotrexate—multiple sclerosis	0.000172	0.000626	CcSEcCtD
Clarithromycin—Fatigue—Dexamethasone—multiple sclerosis	0.000172	0.000626	CcSEcCtD
Clarithromycin—Fatigue—Betamethasone—multiple sclerosis	0.000172	0.000626	CcSEcCtD
Clarithromycin—Pain—Dexamethasone—multiple sclerosis	0.000171	0.000621	CcSEcCtD
Clarithromycin—Pain—Betamethasone—multiple sclerosis	0.000171	0.000621	CcSEcCtD
Clarithromycin—Nervous system disorder—Prednisone—multiple sclerosis	0.00017	0.00062	CcSEcCtD
Clarithromycin—Skin disorder—Prednisone—multiple sclerosis	0.000169	0.000614	CcSEcCtD
Clarithromycin—Hyperhidrosis—Prednisone—multiple sclerosis	0.000168	0.000611	CcSEcCtD
Clarithromycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000168	0.0113	CbGpPWpGaD
Clarithromycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000168	0.0113	CbGpPWpGaD
Clarithromycin—Anorexia—Prednisone—multiple sclerosis	0.000166	0.000602	CcSEcCtD
Clarithromycin—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000165	0.0006	CcSEcCtD
Clarithromycin—Anaemia—Methotrexate—multiple sclerosis	0.000164	0.000598	CcSEcCtD
Clarithromycin—Feeling abnormal—Betamethasone—multiple sclerosis	0.000164	0.000598	CcSEcCtD
Clarithromycin—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000164	0.000598	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000163	0.000593	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000163	0.000593	CcSEcCtD
Clarithromycin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000162	0.000589	CcSEcCtD
Clarithromycin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000162	0.000588	CcSEcCtD
Clarithromycin—Malaise—Methotrexate—multiple sclerosis	0.00016	0.000584	CcSEcCtD
Clarithromycin—Vertigo—Methotrexate—multiple sclerosis	0.00016	0.000581	CcSEcCtD
Clarithromycin—Leukopenia—Methotrexate—multiple sclerosis	0.000159	0.000579	CcSEcCtD
Clarithromycin—Urticaria—Betamethasone—multiple sclerosis	0.000159	0.000576	CcSEcCtD
Clarithromycin—Urticaria—Dexamethasone—multiple sclerosis	0.000159	0.000576	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000158	0.000576	CcSEcCtD
Clarithromycin—Dizziness—Prednisolone—multiple sclerosis	0.000158	0.000575	CcSEcCtD
Clarithromycin—Asthenia—Triamcinolone—multiple sclerosis	0.000158	0.000574	CcSEcCtD
Clarithromycin—Body temperature increased—Betamethasone—multiple sclerosis	0.000158	0.000574	CcSEcCtD
Clarithromycin—Abdominal pain—Betamethasone—multiple sclerosis	0.000158	0.000574	CcSEcCtD
Clarithromycin—Abdominal pain—Dexamethasone—multiple sclerosis	0.000158	0.000574	CcSEcCtD
Clarithromycin—Body temperature increased—Dexamethasone—multiple sclerosis	0.000158	0.000574	CcSEcCtD
Clarithromycin—Asthenia—Methylprednisolone—multiple sclerosis	0.000157	0.000573	CcSEcCtD
Clarithromycin—Insomnia—Prednisone—multiple sclerosis	0.000157	0.000572	CcSEcCtD
Clarithromycin—Paraesthesia—Prednisone—multiple sclerosis	0.000156	0.000567	CcSEcCtD
Clarithromycin—Pruritus—Triamcinolone—multiple sclerosis	0.000156	0.000566	CcSEcCtD
Clarithromycin—Cough—Methotrexate—multiple sclerosis	0.000155	0.000565	CcSEcCtD
Clarithromycin—Pruritus—Methylprednisolone—multiple sclerosis	0.000155	0.000565	CcSEcCtD
Clarithromycin—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000155	0.0105	CbGpPWpGaD
Clarithromycin—Convulsion—Methotrexate—multiple sclerosis	0.000154	0.000561	CcSEcCtD
Clarithromycin—Dyspepsia—Prednisone—multiple sclerosis	0.000153	0.000556	CcSEcCtD
Clarithromycin—Myalgia—Methotrexate—multiple sclerosis	0.000152	0.000551	CcSEcCtD
Clarithromycin—Chest pain—Methotrexate—multiple sclerosis	0.000152	0.000551	CcSEcCtD
Clarithromycin—Decreased appetite—Prednisone—multiple sclerosis	0.000151	0.000549	CcSEcCtD
Clarithromycin—Rash—Prednisolone—multiple sclerosis	0.000151	0.000548	CcSEcCtD
Clarithromycin—Dermatitis—Prednisolone—multiple sclerosis	0.000151	0.000548	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00015	0.000547	CcSEcCtD
Clarithromycin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00015	0.000546	CcSEcCtD
Clarithromycin—Fatigue—Prednisone—multiple sclerosis	0.00015	0.000545	CcSEcCtD
Clarithromycin—Headache—Prednisolone—multiple sclerosis	0.00015	0.000545	CcSEcCtD
Clarithromycin—Discomfort—Methotrexate—multiple sclerosis	0.00015	0.000544	CcSEcCtD
Clarithromycin—Constipation—Prednisone—multiple sclerosis	0.000149	0.00054	CcSEcCtD
Clarithromycin—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000148	0.01	CbGpPWpGaD
Clarithromycin—Confusional state—Methotrexate—multiple sclerosis	0.000146	0.000533	CcSEcCtD
Clarithromycin—Dizziness—Triamcinolone—multiple sclerosis	0.000145	0.000529	CcSEcCtD
Clarithromycin—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000145	0.000528	CcSEcCtD
Clarithromycin—Dizziness—Methylprednisolone—multiple sclerosis	0.000145	0.000528	CcSEcCtD
Clarithromycin—Infection—Methotrexate—multiple sclerosis	0.000144	0.000525	CcSEcCtD
Clarithromycin—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000144	0.00971	CbGpPWpGaD
Clarithromycin—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000144	0.00971	CbGpPWpGaD
Clarithromycin—Feeling abnormal—Prednisone—multiple sclerosis	0.000143	0.000521	CcSEcCtD
Clarithromycin—Asthenia—Dexamethasone—multiple sclerosis	0.000143	0.000521	CcSEcCtD
Clarithromycin—Asthenia—Betamethasone—multiple sclerosis	0.000143	0.000521	CcSEcCtD
Clarithromycin—Nervous system disorder—Methotrexate—multiple sclerosis	0.000142	0.000518	CcSEcCtD
Clarithromycin—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000142	0.000517	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000142	0.000517	CcSEcCtD
Clarithromycin—Nausea—Prednisolone—multiple sclerosis	0.000142	0.000517	CcSEcCtD
Clarithromycin—Pruritus—Dexamethasone—multiple sclerosis	0.000141	0.000513	CcSEcCtD
Clarithromycin—Pruritus—Betamethasone—multiple sclerosis	0.000141	0.000513	CcSEcCtD
Clarithromycin—Skin disorder—Methotrexate—multiple sclerosis	0.000141	0.000513	CcSEcCtD
Clarithromycin—Hyperhidrosis—Methotrexate—multiple sclerosis	0.00014	0.000511	CcSEcCtD
Clarithromycin—Vomiting—Triamcinolone—multiple sclerosis	0.00014	0.000508	CcSEcCtD
Clarithromycin—Vomiting—Methylprednisolone—multiple sclerosis	0.00014	0.000507	CcSEcCtD
Clarithromycin—Rash—Triamcinolone—multiple sclerosis	0.000139	0.000504	CcSEcCtD
Clarithromycin—Dermatitis—Triamcinolone—multiple sclerosis	0.000139	0.000504	CcSEcCtD
Clarithromycin—Anorexia—Methotrexate—multiple sclerosis	0.000138	0.000503	CcSEcCtD
Clarithromycin—Rash—Methylprednisolone—multiple sclerosis	0.000138	0.000503	CcSEcCtD
Clarithromycin—Dermatitis—Methylprednisolone—multiple sclerosis	0.000138	0.000503	CcSEcCtD
Clarithromycin—Urticaria—Prednisone—multiple sclerosis	0.000138	0.000502	CcSEcCtD
Clarithromycin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000138	0.00933	CbGpPWpGaD
Clarithromycin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000138	0.00933	CbGpPWpGaD
Clarithromycin—Headache—Triamcinolone—multiple sclerosis	0.000138	0.000501	CcSEcCtD
Clarithromycin—Headache—Methylprednisolone—multiple sclerosis	0.000137	0.0005	CcSEcCtD
Clarithromycin—Body temperature increased—Prednisone—multiple sclerosis	0.000137	0.0005	CcSEcCtD
Clarithromycin—Abdominal pain—Prednisone—multiple sclerosis	0.000137	0.0005	CcSEcCtD
Clarithromycin—Diarrhoea—Betamethasone—multiple sclerosis	0.000137	0.000497	CcSEcCtD
Clarithromycin—Diarrhoea—Dexamethasone—multiple sclerosis	0.000137	0.000497	CcSEcCtD
Clarithromycin—SLC22A7—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000136	0.00923	CbGpPWpGaD
Clarithromycin—CYP3A7—Biological oxidations—CYP24A1—multiple sclerosis	0.000136	0.00923	CbGpPWpGaD
Clarithromycin—CYP3A7—Biological oxidations—CYP27B1—multiple sclerosis	0.000136	0.00923	CbGpPWpGaD
Clarithromycin—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000136	0.00921	CbGpPWpGaD
Clarithromycin—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000136	0.00921	CbGpPWpGaD
Clarithromycin—CYP3A7—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000135	0.0091	CbGpPWpGaD
Clarithromycin—CYP3A7—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000135	0.0091	CbGpPWpGaD
Clarithromycin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000132	0.000481	CcSEcCtD
Clarithromycin—Dizziness—Dexamethasone—multiple sclerosis	0.000132	0.00048	CcSEcCtD
Clarithromycin—Dizziness—Betamethasone—multiple sclerosis	0.000132	0.00048	CcSEcCtD
Clarithromycin—Insomnia—Methotrexate—multiple sclerosis	0.000131	0.000478	CcSEcCtD
Clarithromycin—Nausea—Triamcinolone—multiple sclerosis	0.000131	0.000475	CcSEcCtD
Clarithromycin—Paraesthesia—Methotrexate—multiple sclerosis	0.00013	0.000474	CcSEcCtD
Clarithromycin—Nausea—Methylprednisolone—multiple sclerosis	0.00013	0.000474	CcSEcCtD
Clarithromycin—Dyspnoea—Methotrexate—multiple sclerosis	0.00013	0.000471	CcSEcCtD
Clarithromycin—Somnolence—Methotrexate—multiple sclerosis	0.000129	0.00047	CcSEcCtD
Clarithromycin—Hypersensitivity—Prednisone—multiple sclerosis	0.000128	0.000466	CcSEcCtD
Clarithromycin—Dyspepsia—Methotrexate—multiple sclerosis	0.000128	0.000465	CcSEcCtD
Clarithromycin—Vomiting—Dexamethasone—multiple sclerosis	0.000127	0.000461	CcSEcCtD
Clarithromycin—Vomiting—Betamethasone—multiple sclerosis	0.000127	0.000461	CcSEcCtD
Clarithromycin—Decreased appetite—Methotrexate—multiple sclerosis	0.000126	0.000459	CcSEcCtD
Clarithromycin—Rash—Betamethasone—multiple sclerosis	0.000126	0.000458	CcSEcCtD
Clarithromycin—Rash—Dexamethasone—multiple sclerosis	0.000126	0.000458	CcSEcCtD
Clarithromycin—Dermatitis—Dexamethasone—multiple sclerosis	0.000126	0.000457	CcSEcCtD
Clarithromycin—Dermatitis—Betamethasone—multiple sclerosis	0.000126	0.000457	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000125	0.000456	CcSEcCtD
Clarithromycin—Fatigue—Methotrexate—multiple sclerosis	0.000125	0.000455	CcSEcCtD
Clarithromycin—Headache—Dexamethasone—multiple sclerosis	0.000125	0.000455	CcSEcCtD
Clarithromycin—Headache—Betamethasone—multiple sclerosis	0.000125	0.000455	CcSEcCtD
Clarithromycin—Asthenia—Prednisone—multiple sclerosis	0.000125	0.000453	CcSEcCtD
Clarithromycin—Pain—Methotrexate—multiple sclerosis	0.000124	0.000452	CcSEcCtD
Clarithromycin—Pruritus—Prednisone—multiple sclerosis	0.000123	0.000447	CcSEcCtD
Clarithromycin—Feeling abnormal—Methotrexate—multiple sclerosis	0.00012	0.000435	CcSEcCtD
Clarithromycin—Diarrhoea—Prednisone—multiple sclerosis	0.000119	0.000432	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000119	0.000432	CcSEcCtD
Clarithromycin—Nausea—Betamethasone—multiple sclerosis	0.000119	0.000431	CcSEcCtD
Clarithromycin—Nausea—Dexamethasone—multiple sclerosis	0.000119	0.000431	CcSEcCtD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000118	0.008	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—C4A—multiple sclerosis	0.000118	0.00797	CbGpPWpGaD
Clarithromycin—Urticaria—Methotrexate—multiple sclerosis	0.000115	0.00042	CcSEcCtD
Clarithromycin—Dizziness—Prednisone—multiple sclerosis	0.000115	0.000418	CcSEcCtD
Clarithromycin—Body temperature increased—Methotrexate—multiple sclerosis	0.000115	0.000418	CcSEcCtD
Clarithromycin—Abdominal pain—Methotrexate—multiple sclerosis	0.000115	0.000418	CcSEcCtD
Clarithromycin—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000112	0.00756	CbGpPWpGaD
Clarithromycin—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000112	0.00756	CbGpPWpGaD
Clarithromycin—Vomiting—Prednisone—multiple sclerosis	0.000111	0.000402	CcSEcCtD
Clarithromycin—Rash—Prednisone—multiple sclerosis	0.00011	0.000398	CcSEcCtD
Clarithromycin—Dermatitis—Prednisone—multiple sclerosis	0.000109	0.000398	CcSEcCtD
Clarithromycin—Headache—Prednisone—multiple sclerosis	0.000109	0.000396	CcSEcCtD
Clarithromycin—Hypersensitivity—Methotrexate—multiple sclerosis	0.000107	0.000389	CcSEcCtD
Clarithromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000106	0.0072	CbGpPWpGaD
Clarithromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000106	0.0072	CbGpPWpGaD
Clarithromycin—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000105	0.00711	CbGpPWpGaD
Clarithromycin—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000105	0.00711	CbGpPWpGaD
Clarithromycin—Asthenia—Methotrexate—multiple sclerosis	0.000104	0.000379	CcSEcCtD
Clarithromycin—Nausea—Prednisone—multiple sclerosis	0.000103	0.000375	CcSEcCtD
Clarithromycin—Pruritus—Methotrexate—multiple sclerosis	0.000103	0.000374	CcSEcCtD
Clarithromycin—Diarrhoea—Methotrexate—multiple sclerosis	9.94e-05	0.000361	CcSEcCtD
Clarithromycin—CYP3A5—Biological oxidations—CYP24A1—multiple sclerosis	9.86e-05	0.00667	CbGpPWpGaD
Clarithromycin—CYP3A5—Biological oxidations—CYP27B1—multiple sclerosis	9.86e-05	0.00667	CbGpPWpGaD
Clarithromycin—CYP3A5—Metapathway biotransformation—CYP24A1—multiple sclerosis	9.73e-05	0.00658	CbGpPWpGaD
Clarithromycin—CYP3A5—Metapathway biotransformation—CYP27B1—multiple sclerosis	9.73e-05	0.00658	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	9.61e-05	0.0065	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	9.61e-05	0.0065	CbGpPWpGaD
Clarithromycin—Dizziness—Methotrexate—multiple sclerosis	9.61e-05	0.000349	CcSEcCtD
Clarithromycin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	9.55e-05	0.00646	CbGpPWpGaD
Clarithromycin—SLC22A7—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	9.53e-05	0.00645	CbGpPWpGaD
Clarithromycin—Vomiting—Methotrexate—multiple sclerosis	9.24e-05	0.000336	CcSEcCtD
Clarithromycin—Rash—Methotrexate—multiple sclerosis	9.16e-05	0.000333	CcSEcCtD
Clarithromycin—Dermatitis—Methotrexate—multiple sclerosis	9.15e-05	0.000333	CcSEcCtD
Clarithromycin—SLC22A7—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	9.15e-05	0.00619	CbGpPWpGaD
Clarithromycin—Headache—Methotrexate—multiple sclerosis	9.1e-05	0.000331	CcSEcCtD
Clarithromycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	8.9e-05	0.00602	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	8.74e-05	0.00591	CbGpPWpGaD
Clarithromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	8.63e-05	0.00584	CbGpPWpGaD
Clarithromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	8.63e-05	0.00584	CbGpPWpGaD
Clarithromycin—Nausea—Methotrexate—multiple sclerosis	8.63e-05	0.000314	CcSEcCtD
Clarithromycin—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	8.29e-05	0.00561	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	8.25e-05	0.00558	CbGpPWpGaD
Clarithromycin—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	7.62e-05	0.00516	CbGpPWpGaD
Clarithromycin—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	7.62e-05	0.00516	CbGpPWpGaD
Clarithromycin—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	7.52e-05	0.00509	CbGpPWpGaD
Clarithromycin—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	7.52e-05	0.00509	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	7.49e-05	0.00506	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	7.43e-05	0.00502	CbGpPWpGaD
Clarithromycin—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.13e-05	0.00482	CbGpPWpGaD
Clarithromycin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	7.11e-05	0.00481	CbGpPWpGaD
Clarithromycin—SLC22A7—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.93e-05	0.00469	CbGpPWpGaD
Clarithromycin—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	6.56e-05	0.00444	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	6.49e-05	0.00439	CbGpPWpGaD
Clarithromycin—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	6.46e-05	0.00437	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—CD28—multiple sclerosis	6.31e-05	0.00427	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	6.04e-05	0.00408	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	5.99e-05	0.00405	CbGpPWpGaD
Clarithromycin—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	5.94e-05	0.00402	CbGpPWpGaD
Clarithromycin—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	5.94e-05	0.00402	CbGpPWpGaD
Clarithromycin—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	5.86e-05	0.00396	CbGpPWpGaD
Clarithromycin—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	5.86e-05	0.00396	CbGpPWpGaD
Clarithromycin—CYP3A7—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.78e-05	0.00391	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—CD40—multiple sclerosis	5.76e-05	0.00389	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	5.67e-05	0.00384	CbGpPWpGaD
Clarithromycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	5.49e-05	0.00371	CbGpPWpGaD
Clarithromycin—SLC22A7—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.48e-05	0.00371	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	5.19e-05	0.00351	CbGpPWpGaD
Clarithromycin—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.15e-05	0.00348	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	5e-05	0.00338	CbGpPWpGaD
Clarithromycin—SLC22A7—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.84e-05	0.00328	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	4.67e-05	0.00316	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	4.58e-05	0.0031	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	4.58e-05	0.0031	CbGpPWpGaD
Clarithromycin—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	4.52e-05	0.00306	CbGpPWpGaD
Clarithromycin—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	4.52e-05	0.00306	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—CD86—multiple sclerosis	4.5e-05	0.00304	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—IL10—multiple sclerosis	4.41e-05	0.00298	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	4.41e-05	0.00298	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—IL4—multiple sclerosis	4.29e-05	0.0029	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	4.2e-05	0.00284	CbGpPWpGaD
Clarithromycin—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.18e-05	0.00282	CbGpPWpGaD
Clarithromycin—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.98e-05	0.00269	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—FAS—multiple sclerosis	3.96e-05	0.00268	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	3.93e-05	0.00266	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	3.89e-05	0.00263	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	3.55e-05	0.0024	CbGpPWpGaD
Clarithromycin—SLC22A7—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.43e-05	0.00232	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—SRM—multiple sclerosis	3.31e-05	0.00224	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—CD80—multiple sclerosis	3.28e-05	0.00222	CbGpPWpGaD
Clarithromycin—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.23e-05	0.00218	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	3.19e-05	0.00216	CbGpPWpGaD
Clarithromycin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.1e-05	0.0021	CbGpPWpGaD
Clarithromycin—CYP3A7—Biological oxidations—POMC—multiple sclerosis	3.07e-05	0.00208	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.93e-05	0.00198	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.93e-05	0.00198	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.92e-05	0.00198	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	2.85e-05	0.00193	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	2.84e-05	0.00192	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	2.84e-05	0.00192	CbGpPWpGaD
Clarithromycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	2.64e-05	0.00179	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	2.59e-05	0.00176	CbGpPWpGaD
Clarithromycin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.52e-05	0.0017	CbGpPWpGaD
Clarithromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.39e-05	0.00162	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—SRM—multiple sclerosis	2.39e-05	0.00162	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	2.33e-05	0.00158	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	2.33e-05	0.00158	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	2.31e-05	0.00157	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—IL2—multiple sclerosis	2.31e-05	0.00156	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.28e-05	0.00154	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.28e-05	0.00154	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.28e-05	0.00154	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	2.22e-05	0.0015	CbGpPWpGaD
Clarithromycin—CYP3A5—Biological oxidations—POMC—multiple sclerosis	2.22e-05	0.0015	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.21e-05	0.0015	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	2.21e-05	0.0015	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	2.17e-05	0.00147	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GPC5—multiple sclerosis	2.13e-05	0.00144	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	2.07e-05	0.0014	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	2.07e-05	0.0014	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.95e-05	0.00132	CbGpPWpGaD
Clarithromycin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.94e-05	0.00131	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—SRM—multiple sclerosis	1.85e-05	0.00125	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—SRM—multiple sclerosis	1.81e-05	0.00122	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	1.8e-05	0.00122	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—RRM1—multiple sclerosis	1.77e-05	0.0012	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.75e-05	0.00118	CbGpPWpGaD
Clarithromycin—SLC22A7—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.74e-05	0.00118	CbGpPWpGaD
Clarithromycin—CYP2C19—Biological oxidations—POMC—multiple sclerosis	1.71e-05	0.00116	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	1.69e-05	0.00114	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	1.69e-05	0.00114	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—TNF—multiple sclerosis	1.68e-05	0.00114	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.55e-05	0.00105	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GPC5—multiple sclerosis	1.54e-05	0.00104	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—SRM—multiple sclerosis	1.44e-05	0.000975	CbGpPWpGaD
Clarithromycin—CYP1A2—Biological oxidations—POMC—multiple sclerosis	1.34e-05	0.000904	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.3e-05	0.000882	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.3e-05	0.000882	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—RRM1—multiple sclerosis	1.28e-05	0.000864	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.27e-05	0.000862	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.27e-05	0.000861	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.27e-05	0.000861	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.19e-05	0.000807	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GPC5—multiple sclerosis	1.16e-05	0.000787	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—SRM—multiple sclerosis	1.11e-05	0.000753	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.03e-05	0.000698	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.02e-05	0.000687	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.02e-05	0.000687	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—BCHE—multiple sclerosis	1.02e-05	0.000687	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	9.93e-06	0.000672	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—RRM1—multiple sclerosis	9.88e-06	0.000668	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—RRM1—multiple sclerosis	9.64e-06	0.000652	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GPC5—multiple sclerosis	9.29e-06	0.000628	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	8.9e-06	0.000602	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	8.88e-06	0.0006	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	8.7e-06	0.000589	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	8.29e-06	0.000561	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	7.84e-06	0.00053	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	7.84e-06	0.00053	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—RRM1—multiple sclerosis	7.7e-06	0.000521	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.67e-06	0.000519	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—BCHE—multiple sclerosis	7.34e-06	0.000496	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GPC5—multiple sclerosis	7.17e-06	0.000485	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.59e-06	0.000445	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—APOE—multiple sclerosis	6.11e-06	0.000413	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6e-06	0.000406	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.97e-06	0.000404	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—RRM1—multiple sclerosis	5.94e-06	0.000402	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—BCHE—multiple sclerosis	5.67e-06	0.000384	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.57e-06	0.000377	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—BCHE—multiple sclerosis	5.54e-06	0.000375	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—POMC—multiple sclerosis	5.25e-06	0.000355	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.13e-06	0.000347	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—ALB—multiple sclerosis	4.78e-06	0.000324	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.68e-06	0.000316	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—BCHE—multiple sclerosis	4.42e-06	0.000299	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—APOE—multiple sclerosis	4.42e-06	0.000299	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—POMC—multiple sclerosis	3.79e-06	0.000257	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—ALB—multiple sclerosis	3.46e-06	0.000234	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—APOE—multiple sclerosis	3.41e-06	0.000231	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—BCHE—multiple sclerosis	3.41e-06	0.000231	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—APOE—multiple sclerosis	3.33e-06	0.000225	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—POMC—multiple sclerosis	2.93e-06	0.000198	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—POMC—multiple sclerosis	2.86e-06	0.000194	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ALB—multiple sclerosis	2.67e-06	0.000181	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—APOE—multiple sclerosis	2.66e-06	0.00018	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—ALB—multiple sclerosis	2.61e-06	0.000177	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—POMC—multiple sclerosis	2.29e-06	0.000155	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ALB—multiple sclerosis	2.08e-06	0.000141	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—APOE—multiple sclerosis	2.05e-06	0.000139	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—POMC—multiple sclerosis	1.76e-06	0.000119	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ALB—multiple sclerosis	1.61e-06	0.000109	CbGpPWpGaD
